Literature DB >> 18298479

The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.

A J Cameron1, D J Magliano, P Z Zimmet, T A Welborn, S Colagiuri, A M Tonkin, J E Shaw.   

Abstract

OBJECTIVE: To compare the ability of the metabolic syndrome (MetS), a diabetes prediction model (DPM), a noninvasive risk questionnaire and individual glucose measurements to predict future diabetes.
DESIGN: Five-year longitudinal cohort study. Tools tested included MetS definitions [World Health Organization, International Diabetes Federation, ATPIII and European Group for the study of Insulin Resistance (EGIR)], the FINnish Diabetes RIsk SCore risk questionnaire, the DPM, fasting and 2-h post load plasma glucose.
SETTING: Adult Australian population.
SUBJECTS: A total of 5842 men and women without diabetes > or =25 years. Response 58%. A total of 224 incident cases of diabetes.
RESULTS: In receiver operating characteristic curve analysis, the MetS was not a better predictor of incident diabetes than the DPM or measurement of glucose. The risk for diabetes among those with prediabetes but not MetS was almost triple that of those with MetS but not prediabetes (9.0% vs. 3.4%). Adjusted for component parts, the MetS was not a significant predictor of incident diabetes, except for EGIR in men [OR 2.1 (95% CI 1.2-3.7)].
CONCLUSIONS: A single fasting glucose measurement may be more effective and efficient than published definitions of the MetS or other risk constructs in predicting incident diabetes. Diagnosis of the MetS did not confer increased risk for incident diabetes independent of its individual components, with an exception for EGIR in men. Given these results, debate surrounding the public health utility of a MetS diagnosis, at least for identification of incident diabetes, is required.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298479     DOI: 10.1111/j.1365-2796.2008.01935.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  27 in total

1.  Association of metabolic syndrome with development of new-onset diabetes after transplantation.

Authors:  Nathaniel D Bayer; Philip T Cochetti; Mysore S Anil Kumar; Valerie Teal; Yonghong Huan; Cataldo Doria; Roy D Bloom; Sylvia E Rosas
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

Review 2.  Metabolic syndrome and lifestyle modification.

Authors:  Mitsuyoshi Takahara; Iichiro Shimomura
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

Review 3.  Thyroid hormones and the metabolic syndrome.

Authors:  K Alexander Iwen; Erich Schröder; Georg Brabant
Journal:  Eur Thyroid J       Date:  2013-05-28

4.  Retinopathy predicts progression of fasting plasma glucose: An Early Diabetes Intervention Program (EDIP) analysis.

Authors:  Yash R Patel; M Sue Kirkman; Robert V Considine; Tamara S Hannon; Kieren J Mather
Journal:  J Diabetes Complications       Date:  2016-11-12       Impact factor: 2.852

5.  Major depression and the metabolic syndrome.

Authors:  Debra L Foley; Katherine I Morley; Pamela A F Madden; Andrew C Heath; John B Whitfield; Nicholas G Martin
Journal:  Twin Res Hum Genet       Date:  2010-08       Impact factor: 1.587

6.  Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: the SWAN Sleep Study.

Authors:  Martica H Hall; Michele L Okun; MaryFran Sowers; Karen A Matthews; Howard M Kravitz; Kimberly Hardin; Daniel J Buysse; Joyce T Bromberger; Jane F Owens; Irina Karpov; Mark H Sanders
Journal:  Sleep       Date:  2012-06-01       Impact factor: 5.849

7.  The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts.

Authors:  Maarit A Laaksonen; Paul Knekt; Harri Rissanen; Tommi Härkänen; Esa Virtala; Jukka Marniemi; Arpo Aromaa; Markku Heliövaara; Antti Reunanen
Journal:  Eur J Epidemiol       Date:  2009-12-13       Impact factor: 8.082

8.  The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation.

Authors:  R K Simmons; K G M M Alberti; E A M Gale; S Colagiuri; J Tuomilehto; Q Qiao; A Ramachandran; N Tajima; I Brajkovich Mirchov; A Ben-Nakhi; G Reaven; B Hama Sambo; S Mendis; G Roglic
Journal:  Diabetologia       Date:  2009-12-11       Impact factor: 10.122

9.  Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrome: a prospective cohort study.

Authors:  Camila Furtado de Souza; Mériane Boeira Dalzochio; Francisco Jorge Arsego de Oliveira; Jorge Luiz Gross; Cristiane Bauermann Leitão
Journal:  Diabetol Metab Syndr       Date:  2012-06-08       Impact factor: 3.320

10.  Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study.

Authors:  Naoko Mukai; Yasufumi Doi; Toshiharu Ninomiya; Jun Hata; Koji Yonemoto; Masanori Iwase; Mitsuo Iida; Yutaka Kiyohara
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.